Study to Investigate the Effect of KUC 7483 CL on the QT/QTc Interval of the ECG in Comparison to Placebo and Moxifloxacin in Healthy Male and Female Volunteers

NCT02256735 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

39

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Treatment A
DRUG: Treatment B
DRUG: Treatment C
DRUG: Treatment D
DRUG: Placebo
DRUG: Moxifloxacin

Sponsor

Boehringer Ingelheim